BMS petitions SCOTUS to revive $1.2bn win

16-06-2022

BMS petitions SCOTUS to revive $1.2bn win

nitpicker / Shutterstock.com

BMS unit Juno Therapeutics and the Sloan Kettering Institute for Cancer Research have urged the US Supreme Court to reinstate their $1.2 billion win in a patent clash with Kite Pharma, a subsidiary of Gilead.


Kite Pharmaceuticals, Juno Therapeutics, Bristol Myers Squibb, BMS, Gilead Sciences, SCOTUS, Supreme Court, patent infringement, innovation

LSIPR